🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT06036381
Recruiting Observational

Spatial and Temporal Characterization of Gliomas Using Radiomic Analysis

NCT06036381 · tracked via the Priya Life Science India tracker
Sponsor
Tata Memorial Centre
Phase
Observational
Started
2024-02-15
Last updated
2025-04-09

Condition(s) studied

Glioma

Investigational drug(s) / intervention(s)

Radiomic analysis of imaging - MRI, PET, CT

Radiomic analysis of imaging - MRI, PET, CT: Radiomic analysis of imaging will be undertaken as a standard of care to develop computational algorithms for patients treated in our institution.

Study summary

Glioma are type of primary brain tumors arising within the substance of brain. Different type of gliomas are seen which are classified depending upon pathological examination and advanced molecular techniques, which help to determine the aggressiveness of the tumor and outcomes. Artificial intelligence uses advanced analytical process aided by computer which can be undertaken on the medical images. We plan to use artificial intelligence techniques to identify the abnormal areas within the brain representing tumor from the radiological images. Also, similar approach will be undertaken to classify gliomas with good or bad prognosis, to differentiate glioma from other type of brain tumors, and to detect response after treatment.

Eligibility

Sex
ALL
Min age
1 Year
Max age
Healthy volunteers
No
Inclusion Criteria: * Patients with glioma or glioma-mimicking pathology with imaging available in TMC between January 2010 and December 2022. Exclusion Criteria: * Imaging done outside TMC. * Motion artifacts or other artifacts causing image degradation. * Size of tumor or region of interest \< 1 cm in the largest dimension

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tata Memorial Hospital Mumbai Maharashtra Recruiting

More Tata Memorial Centre trials in India

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06036381 on ClinicalTrials.gov ↗ ← All trials in India